Live from the NIH registry
Studies recruiting near Winston-Salem right now
Top 25 of 587 recruiting studies, sorted by proximity — each links to its official registry page
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
N/A
Observational 20,000 participants sought
Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Novant Health Forsyth Medical Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: SWOG Cancer Research Network
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Brookview Hills Research Associates, LLC — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Novo Nordisk A/S
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Novant Health Cancer Institute — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Hoffmann-La Roche
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Novant Health Forsyth Medical Center ( Site 0206) — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Greensboro, NC — Greensboro, North Carolina (26.3 mi)
· Sponsor: Mediar Therapeutics
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Novant Health Pharmacy Oncology Specialists — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Bristol-Myers Squibb
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Metastatic Breast Cancer, Leptomeningeal Disease
Phase 2
Interventional 16 participants sought
Comprehensive Cancer Center at Wake Forest University (CCCWFU) — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Huntington's Disease
N/A
Observational 2,500 participants sought
Wake Forest University — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: University College, London
Effects of Systematic Cervical Exam Training on Labor and Delivery Care
Delivery Problem, Cervix; Pregnancy
N/A
Interventional 1,125 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
Gastroparesis, Idiopathic Gastric Motility Disorder
N/A
Observational 150 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Johns Hopkins Bloomberg School of Public Health
Evaluation of the Pathobiology of CALR-mutated MPN Cells
Myeloproliferative Neoplasm
N/A
Observational 35 participants sought
Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Wake Forest University Health Sciences
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Headache Wellness Center /ID# 270568 — Greensboro, North Carolina (26.3 mi)
· Sponsor: AbbVie
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
Vulvovaginal Candidiasis (VVC), Yeast Vaginitis
N/A
Interventional 55 participants sought
Lyndhurst Clinical Research — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Coologics, Inc
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
HPV, HPV - Anogenital Human Papilloma Virus Infection
N/A
Interventional 260 participants sought
Lyndhurst Clinical Research (Unified) — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Mel Mont Medical
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Children's Oncology Group
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Wake Forest University Health Sciences — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Giselle Sholler
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: AstraZeneca
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Cone Health Cancer Center — Greensboro, North Carolina (26.3 mi)
· Sponsor: NRG Oncology
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Novartis Pharmaceuticals
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
Depression, Cancer
N/A
Interventional 208 participants sought
Wake Forest University — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: East Carolina University
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Lyell Immunopharma, Inc.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
All-Trials Clinical Research- Site Number : 8400008 — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Sanofi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Overweight, Obesity
Phase 3
Interventional 900 participants sought
Medication Management — Greensboro, North Carolina (26.3 mi)
· Sponsor: Eli Lilly and Company
A Clinical Study to Evaluate the Efficacy and SPF of Two Test Materials According to an Adaptation of the Guidelines of the FDA Sunscreen Drug Products for Over-the-Counter Human Use
Epidermis, Ultraviolet Exposure
Phase 4
Interventional 60 participants sought
Eurofins | CRL, Cosmetics LLC — Winston-Salem, North Carolina (1.0 mi)
· Sponsor: Good Molecules, LLC